Ellodi Pharmaceuticals, LP
4 clinical trials · Sponsor
◉ Watch Ellodi Pharmaceuticals, LP
| Record | Firm | Date |
|---|---|---|
| 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) (NCT05634746) | Ellodi Pharmaceuticals, LP | 2022-12-29 |
| Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial (NCT05083312) | Ellodi Pharmaceuticals, LP | 2021-09-30 |
| Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) (NCT04281108) | Ellodi Pharmaceuticals, LP | 2020-01-30 |
Track Ellodi Pharmaceuticals, LP automatically
Every clearance here is in the API, with alerts when new ones post.